Wilbanks Smith & Thomas Asset Management LLC boosted its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 8.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,462 shares of the company’s stock after buying an additional 353 shares during the period. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Express Scripts Holding were worth $294,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC bought a new position in Express Scripts Holding during the fourth quarter worth approximately $952,000. Vident Investment Advisory LLC boosted its position in Express Scripts Holding by 0.9% in the fourth quarter. Vident Investment Advisory LLC now owns 30,927 shares of the company’s stock worth $2,127,000 after buying an additional 264 shares during the period. Israel Discount Bank of New York GFN bought a new position in Express Scripts Holding during the fourth quarter worth approximately $468,000. Dodge & Cox bought a new position in Express Scripts Holding during the fourth quarter worth approximately $1,456,850,000. Finally, Perigon Wealth Management LLC boosted its position in Express Scripts Holding by 155.3% in the fourth quarter. Perigon Wealth Management LLC now owns 2,387 shares of the company’s stock worth $171,000 after buying an additional 1,452 shares during the period. 90.48% of the stock is owned by institutional investors and hedge funds.
Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.63% on Thursday, reaching $62.37. The company’s stock had a trading volume of 655,016 shares. The stock has a market cap of $36.02 billion, a P/E ratio of 10.82 and a beta of 0.90. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.61. The firm’s 50-day moving average price is $63.15 and its 200-day moving average price is $64.92.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company’s revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.57 EPS. On average, analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Company (NASDAQ:ESRX) Stake Raised by Wilbanks Smith & Thomas Asset Management LLC” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/08/03/wilbanks-smith-thomas-asset-management-llc-buys-353-shares-of-express-scripts-holding-company-nasdaqesrx-updated.html.
A number of research firms have commented on ESRX. Needham & Company LLC began coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating for the company. BidaskClub cut shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Cowen and Company reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research report on Friday, June 9th. ValuEngine cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Evercore ISI dropped their target price on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a report on Wednesday, April 26th. Four analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $70.81.
In related news, VP Phyllis S. Anderson sold 1,100 shares of the firm’s stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.68% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.
